• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Heron Therapeutics

graphic of a saw cutting off the branch of a tree with employees on it resembling axing staff
Biotech

Heron lays off 25% of staff in second round of cuts in 13 months

Heron is going through another round of layoffs after a review of the business by the company's new management team.
Max Bayer Jul 24, 2023 12:44pm
parachute portugal Albufeira

Amgen poaches Moderna CMO—Chutes & Ladders

Jun 16, 2023 9:30am
image of a few paragliders

Amarin CEO abruptly resigns—Chutes & Ladders

Apr 7, 2023 9:30am
layoffs

Hit with 'current market realities,' Heron axes a 3rd of staff

Jun 30, 2022 2:24pm
Heron Therapeutics

Heron's wings clipped again with another FDA rejection

Jun 29, 2020 9:25am
Surgery

Heron’s anesthetic aces phase 2 trials, reducing opioid use

Jun 21, 2018 10:24am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings